Key Points Considering that the semiconductor maker is in the bankruptcy process, you can bet it's much less. On a brighter note, its reorganization plan has been accepted, and it should soon exit the proceedings. 10 stocks we like better than Wolfspeed › Is a recovery story in the works for Wolfspeed (NYSE: WOLF)? After all, the next-gen semiconductor maker says it'll soon emerge from Chapter 11 bankruptcy protection with a much cleaner balance sheet; it also faces a promising market for the silic ...

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Dive Brief: CVS pharmacy services subsidiary Omnicare has filed for Chapter 11 bankruptcy after being hit with a $949 million federal judgment over improper billing of government healthcare programs. Omnicare claimed up to $500 million in assets and between $1 billion and $10 billion in debts in its bankruptcy petition with a Texas court on Monday. Omnic ...

Wolfspeed's stock is still highly volatile.Shares of Wolfspeed (WOLF -9.56%) are on the move this week, up 5.6% as of market close on Thursday, though they gained as much as 25.8% earlier in the week. The jump comes as the S&P 500 and Nasdaq-100 gained 0.7% and 1.5%, respectively.The embattled chipmaker's stock is up and down this week after gaining nearly 90% last week. Investors are weighing what the company might be worth after exiting bankruptcy.Wolfspeed could soon exit bankruptcyWolfspeed management e ...

公司破产重组 - 公司已正式申请第11章破产保护 启动重组计划以削减数十亿美元债务[1] - 破产申请提交于德克萨斯州南区法院 距离公布债权人重组协议仅8天[2] - 采用预打包破产方案 获得97%优先担保债务和67%可转换债务持有人的支持 日本半导体公司瑞萨参与其中[3] 债务与资本结构 - 预计通过破产削减70%债务（约46亿美元） 计划9月底完成重组[3] - 2026年5月首笔可转换债务到期前 公司持有13亿美元现金但仍选择破产[10] - 曾拒绝2026年债务重组提议 寻求更"全面"解决方案[10] 业务转型与困境 - 原名Cree 为转型碳化硅半导体业务累计负债超60亿美元 放弃传统LED照明业务[5] - 2022年投资纽约州晶圆厂并宣布50亿美元材料厂建设计划 承诺创造1800个岗位[5] - 受制造延迟 电动车需求疲软及竞争加剧影响 关闭达勒姆设备厂并暂停德国数十亿美元项目[6] 运营调整 - 全球员工数量从5000人缩减25%以上 多数裁员发生在北卡罗来纳州总部[4] - 2024年11月更换任职7年的CEO Greg Lowe[6] - 新设破产专题网站 承诺维持正常材料交付和员工薪酬福利[12] 政府支持与市场反应 - 2024年10月获得7.5亿美元CHIPS法案补贴 但以完成2026年债务重组为前提[7] - 破产首日股价收于04美元/股 次日早盘翻倍至08美元以上[12] - 争取保持纽交所上市资格 但承认存在退市风险[12]

文章核心观点 23andMe打算于2025年6月6日左右向美国证券交易委员会提交25表格退市通知，从纳斯达克摘牌，后续还将提交15表格进行注销登记 [1][2] 公司动态 - 公司于2025年3月23日宣布其与部分子公司在美国密苏里东区破产法院启动自愿第11章破产程序 [2] - 纳斯达克于2025年3月31日开市时暂停公司A类普通股交易，并通知公司将提交25表格 [1] - 公司将主动提交25表格，以便后续提交15表格向美国证券交易委员会注销登记 [1][2] 公司简介 - 23andMe是一家以基因技术为导向的消费者医疗保健和生物技术公司，致力于开创更健康的未来 [3]